Shin Mineishi

Shin Mineishi, MD is a Professor in the Department of Medicine at Penn State University College of Medicine, where he serves as Director of Bone Marrow Transplantation within the Division of Hematology and Oncology at the Penn State Cancer Institute. His academic career spans over three decades with continuous research output from 1989 through 2025, demonstrating sustained scholarly activity in the field of transplantation medicine.

Dr. Mineishi's research focuses primarily on allogeneic hematopoietic stem cell transplantation, with particular expertise in graft-versus-host disease, stem cell transplantation, and related immunological aspects of cancer treatment. His fingerprint analysis shows strong concentration in transplantation immunology, with 100% focus on allogeneic hematopoietic stem cell transplantation and 81% on graft-versus-host disease.

Recent publication trends (2021-2025) show consistent scholarly output with 6 publications in 2021, 5 in 2022, 5 in 2023, 8 in 2024, and 3 in 2025 (including works currently in press). His research spans diverse subfields including chimerism assessment, novel preconditioning regimens, immunotherapeutic approaches to leukemia, and the evolution of stem cell transplantation techniques. Current work demonstrates particular focus on acute myeloid leukemia treatment and innovative approaches to managing graft-versus-host disease.

With an h-index of 46 and 7,443 citations, Dr. Mineishi has established himself as a significant contributor to the field of hematopoietic stem cell transplantation and related disciplines.

Dr. Mineishi directs the Bone Marrow Transplantation program at Penn State Cancer Institute, leading clinical and research efforts in next-generation therapies for hematological malignancies. His work contributes to UN Sustainable Development Goals related to good health and well-being, particularly in advancing cancer treatment options.